GB8626413D0 - Antibodies - Google Patents

Antibodies

Info

Publication number
GB8626413D0
GB8626413D0 GB868626413A GB8626413A GB8626413D0 GB 8626413 D0 GB8626413 D0 GB 8626413D0 GB 868626413 A GB868626413 A GB 868626413A GB 8626413 A GB8626413 A GB 8626413A GB 8626413 D0 GB8626413 D0 GB 8626413D0
Authority
GB
United Kingdom
Prior art keywords
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB868626413A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gilliland L K
Original Assignee
Gilliland L K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilliland L K filed Critical Gilliland L K
Priority to GB868626413A priority Critical patent/GB8626413D0/en
Publication of GB8626413D0 publication Critical patent/GB8626413D0/en
Priority to PCT/GB1987/000782 priority patent/WO1988003566A1/en
Priority to EP19870907124 priority patent/EP0293405A1/en
Priority to JP50649887A priority patent/JPH01501201A/en
Priority to AU81568/87A priority patent/AU616870B2/en
Priority to GB8725812A priority patent/GB2197323B/en
Priority to DK353288A priority patent/DK353288A/en
Pending legal-status Critical Current

Links

GB868626413A 1986-11-05 1986-11-05 Antibodies Pending GB8626413D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GB868626413A GB8626413D0 (en) 1986-11-05 1986-11-05 Antibodies
PCT/GB1987/000782 WO1988003566A1 (en) 1986-11-05 1987-11-04 Antibodies
EP19870907124 EP0293405A1 (en) 1986-11-05 1987-11-04 Antibodies
JP50649887A JPH01501201A (en) 1986-11-05 1987-11-04 antibody
AU81568/87A AU616870B2 (en) 1986-11-05 1987-11-04 Bi-specific antibodies with cytotoxic activity
GB8725812A GB2197323B (en) 1986-11-05 1987-11-04 Antibodies
DK353288A DK353288A (en) 1986-11-05 1988-06-27 ANTIBODIES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868626413A GB8626413D0 (en) 1986-11-05 1986-11-05 Antibodies

Publications (1)

Publication Number Publication Date
GB8626413D0 true GB8626413D0 (en) 1986-12-03

Family

ID=10606822

Family Applications (2)

Application Number Title Priority Date Filing Date
GB868626413A Pending GB8626413D0 (en) 1986-11-05 1986-11-05 Antibodies
GB8725812A Expired - Fee Related GB2197323B (en) 1986-11-05 1987-11-04 Antibodies

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB8725812A Expired - Fee Related GB2197323B (en) 1986-11-05 1987-11-04 Antibodies

Country Status (5)

Country Link
EP (1) EP0293405A1 (en)
JP (1) JPH01501201A (en)
AU (1) AU616870B2 (en)
GB (2) GB8626413D0 (en)
WO (1) WO1988003566A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2621127B1 (en) * 1987-09-30 1992-01-31 Roussy Inst Gustave MONOCLONAL ANTIBODIES RECOGNIZING A GAMMA CHAIN EPITOPE OF HUMAN T CELL SURFACE RECEPTORS, LINE OF HYBRIDOMA CELLS PRODUCING THE SAME, AND USE OF THIS MONOCLONAL ANTIBODY
EP0334300A1 (en) * 1988-03-21 1989-09-27 Neorx Corporation The use of monoclonal antibodies and conjugates thereof as signals to direct sensitized effector cells to tumor sites
US5223426A (en) * 1988-12-15 1993-06-29 T Cell Sciences, Inc. Monoclonal antibodies reactive with defined regions of the t-cell antigen receptor
US5766947A (en) * 1988-12-14 1998-06-16 Astra Ab Monoclonal antibodies reactive with an epitope of a Vβ3.1 variable region of a T cell receptor
US5897861A (en) * 1989-06-29 1999-04-27 Medarex, Inc. Bispecific reagents for AIDS therapy
ATE144793T1 (en) * 1989-06-29 1996-11-15 Medarex Inc BISPECIFIC REAGENTS FOR AIDS THERAPY
US5858363A (en) * 1990-07-20 1999-01-12 Pharmacia & Upjohn Ab Target specific antibody-superantigen conjugates and their preparation
KR100189024B1 (en) * 1990-07-20 1999-06-01 존 해던쉬트롬 Target specific antibody-superantigen conjugates and their preparation
JP3105629B2 (en) † 1991-04-23 2000-11-06 サングスタット メディカル コーポレイション Cell activity regulating conjugates of members of specific binding pairs
US5587458A (en) * 1991-10-07 1996-12-24 Aronex Pharmaceuticals, Inc. Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof
US5945311A (en) * 1994-06-03 1999-08-31 GSF--Forschungszentrumfur Umweltund Gesundheit Method for producing heterologous bi-specific antibodies
DE122009000068I2 (en) * 1994-06-03 2011-06-16 Ascenion Gmbh Process for the preparation of heterologous bispecific antibodies
PL211872B1 (en) 2000-03-31 2012-07-31 Purdue Research Foundation Method of treatment using ligand-immunogen conjugates
JP5168538B2 (en) * 2007-05-24 2013-03-21 アボットジャパン株式会社 Antibody-antibody conjugates and application to diagnostic antibodies
EP3916011A1 (en) 2009-06-26 2021-12-01 Regeneron Pharmaceuticals, Inc. Readily isolated bispecific antibodies with native immunoglobulin format
CN103261220B (en) 2010-08-16 2016-06-15 诺夫免疫股份有限公司 For generating the method for polyspecific and multivalent antibody
ES2758051T3 (en) 2011-08-05 2020-05-04 Regeneron Pharma Humanized Universal Light Chain Mice
AR101262A1 (en) 2014-07-26 2016-12-07 Regeneron Pharma PURIFICATION PLATFORM FOR Bispecific Antibodies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
CA1213229A (en) * 1982-04-12 1986-10-28 Gary S. David Antibodies having dual specificities, their preparation and uses therefor

Also Published As

Publication number Publication date
AU616870B2 (en) 1991-11-14
AU8156887A (en) 1988-06-01
WO1988003566A1 (en) 1988-05-19
GB8725812D0 (en) 1987-12-09
GB2197323A (en) 1988-05-18
EP0293405A1 (en) 1988-12-07
JPH01501201A (en) 1989-04-27
GB2197323B (en) 1990-10-31

Similar Documents

Publication Publication Date Title
GB2197322B (en) Antibodies
GB2209757B (en) Altered antibodies
GB8408193D0 (en) Antibodies
GB2197323B (en) Antibodies
GB8608068D0 (en) Monoclonal antibodies
GB8614084D0 (en) Immunoassay
GB8624899D0 (en) Monoclonal antibodies
GB8621910D0 (en) Monoclonal antibodies
GB8505487D0 (en) Antibodies
GB8715347D0 (en) Monoclonal antibodies
GB8726230D0 (en) Antibodies
GB8616174D0 (en) Monoclonal antibodies
GB8629740D0 (en) Immunoassay
GB8710074D0 (en) Antibodies
GB8610202D0 (en) Monoclonal antibodies
GB8610203D0 (en) Monoclonal antibodies
GB8620589D0 (en) Antibodies
GB8610318D0 (en) Antibodies
GB8623088D0 (en) Antibodies
GB8619998D0 (en) Antibodies
GB8621240D0 (en) Antigens
GB2215725B (en) Monoclonal antibodies
GB8729520D0 (en) Antibodies
GB8708648D0 (en) Antibodies
GB8506372D0 (en) Antibodies